MacroGenics, Inc. (MGNX) News

Latest headlines that mention MGNX, newest first · each headline opens the original publisher

MGNX quote

Last price: $3.33
Day change: +2.46%
Next earnings: 2026-11-11

Quote & chart Expected move Insider trading IV rank history

MGNX headlines

latest coverage

Investing.com 4d ago

MacroGenics doses first patient in MGC030 cancer trial

General T3MGNX

Seeking Alpha News 1mo ago

MacroGenics: Inexpensive ADC/TCE Biotech With Multiple Catalysts Ahead

General T2MGNX

Yahoo Finance 2mo ago

Can MacroGenics (MGNX) Turn Gilead Sciences (GILD)’s $10M Milestone Into a Major Pipeline Catalyst?

General T2GILD MGNX

Seeking Alpha 2mo ago

MacroGenics GAAP EPS of -$1.10 misses by $1.02, revenue of $32.83M misses by $26.31M

Earnings T2MGNX

Seeking Alpha News 2mo ago

MacroGenics: Whipsaws On Clinical Data, But The Big Picture Is Still Important

General T2MGNX

Investing.com 2mo ago

Citizens reiterates MacroGenics stock rating ahead of ESMO data

General T3MGNX

Seeking Alpha 2mo ago

MacroGenics slips after early-stage trial data for lead asset

General T2MGNX

Investing.com 3mo ago

Form 144 MACROGENICS For: 13 July

General T3MGNX

Seeking Alpha News 3mo ago

MacroGenics: 'Hold' Potential Best-In-Class B7-H3 ADC And TZIELD Payment

General T2MGNX

Seeking Alpha 3mo ago

MacroGenics gains $24.5M payment from Sanofi for Tzield approval

General T2MGNX SNY

Investing.com 4mo ago

Form 13G MacroGenics For: 5 June

General T3MGNX

Seeking Alpha 5mo ago

MacroGenics to sell manufacturing operations to Bora for $122.5M

General T2MGNX

MGNX news alerts

Get an alert by email or push when a new headline mentions MGNX.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.